Clinical trial with lozenges as local anesthesia for allogeneic bone marrow transplant patients with oral mucositis

Trial Profile

Clinical trial with lozenges as local anesthesia for allogeneic bone marrow transplant patients with oral mucositis

Discontinued
Phase of Trial: Phase II

Latest Information Update: 22 Aug 2016

At a glance

  • Drugs Bupivacaine (Primary)
  • Indications Inflammatory pain
  • Focus Therapeutic Use
  • Acronyms OMBMT Lozenge
  • Most Recent Events

    • 16 Aug 2016 Status changed from completed to discontinued.
    • 04 Aug 2016 Status changed from recruiting to completed.
    • 02 Jun 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top